Skip to main content
. 2018 Jan 4;67(51-52):1419–1427. doi: 10.15585/mmwr.mm675152e1

TABLE 1. Annual number and age-adjusted rate of drug overdose deaths* involving all opioids and prescription opioids,§, by sex, age, race and Hispanic origin,** urbanization level,†† and selected states§§ — United States, 2016 and 2017.

Decedent characteristic All opioids
Prescription opioids
2016
2017
Change from 2016 to 2017¶¶
2016
2017
Change from 2016 to 2017¶¶
No. Rate No. Rate Absolute rate change % Change in rate No. Rate No. Rate Absolute rate change % Change in rate
All
42,249
13.3
47,600
14.9
1.6***
12.0***
17,087
5.2
17,029
5.2
0.0
0.0
Sex
Male
28,498
18.1
32,337
20.4
2.3***
12.7***
9,978
6.2
9,873
6.1
-0.1
-1.6
Female
13,751
8.5
15,263
9.4
0.9***
10.6***
7,109
4.3
7,156
4.2
-0.1
-2.3
Age group (yrs)

0–14
83
0.1
79
0.1
0.0
0.0
60
0.1
50
0.1
0.0
0.0
15–24
4,027
9.3
4,094
9.5
0.2
2.2
1,146
2.6
1,050
2.4
-0.2
-7.7
25–34
11,552
25.9
13,181
29.1
3.2***
12.4***
3,442
7.7
3,408
7.5
-0.2
-2.6
35–44
9,747
24.1
11,149
27.3
3.2***
13.3***
3,727
9.2
3,714
9.1
-0.1
-1.1
45–54
9,074
21.2
10,207
24.1
2.9***
13.7***
4,307
10.1
4,238
10.0
-0.1
-1.0
55–64
6,321
15.2
7,153
17.0
1.8***
11.8***
3,489
8.4
3,509
8.4
0.0
0.0
≥65
1,441
2.9
1,724
3.4
0.5***
17.2***
915
1.9
1,055
2.1
0.2***
10.5***
Sex and age group (yrs)
Male 15–24
2,986
13.4
2,885
13.0
-0.4
-3.0
852
3.8
728
3.3
-0.5***
-13.2***
Male 25–44
15,137
35.4
17,352
40.0
4.6***
13.0***
4,527
10.6
4,516
10.4
-0.2
-1.9
Male 45–64
9,519
23.2
11,061
26.9
3.7***
15.9***
4,124
10.0
4,089
9.9
-0.1
-1.0
Female 15–24
1,041
4.9
1,209
5.7
0.8***
16.3***
294
1.4
322
1.5
0.1
7.1
Female 25–44
6,162
14.5
6,978
16.3
1.8***
12.4***
2,642
6.2
2,606
6.1
-0.1
-1.6
Female 45–64
5,876
13.6
6,299
14.6
1.0***
7.4***
3,672
8.5
3,658
8.5
0.0
0.0
Race and Hispanic origin**
White, non-Hispanic
33,450
17.5
37,113
19.4
1.9***
10.9***
14,167
7.0
13,900
6.9
-0.1
-1.4
Black, non-Hispanic
4,374
10.3
5,513
12.9
2.6***
25.2***
1,392
3.3
1,508
3.5
0.2
6.1
Hispanic
3,440
6.1
3,932
6.8
0.7***
11.5***
1,133
2.1
1,211
2.2
0.1
4.8
American Indian/Alaska Native, non-Hispanic
369
13.9
408
15.7
1.8
12.9
173
6.5
187
7.2
0.7
10.8
Asian/Pacific Islander, non-Hispanic
323
1.5
348
1.6
0.1
6.7
131
0.7
130
0.6
-0.1
-14.3
County urbanization level††

Large central metro
12,903
12.5
14,518
13.9
1.4***
11.2***
4,930
4.7
4,945
4.7
0.0
0.0
Large fringe metro
11,993
15.4
13,594
17.2
1.8***
11.7***
4,209
5.2
4,273
5.2
0.0
0.0
Medium metro
9,264
14.3
10,561
16.2
1.9***
13.3***
3,988
6.0
3,951
5.9
-0.1
-1.7
Small metro
3,224
11.7
3,560
12.9
1.2***
10.3***
1,471
5.2
1,479
5.2
0.0
0.0
Micropolitan (nonmetro)
3,068
12.1
3,462
13.9
1.8***
14.9***
1,475
5.7
1,440
5.6
-0.1
-1.8
Noncore (nonmetro)
1,797
10.5
1,905
11.2
0.7
6.7
1,014
5.7
941
5.3
-0.4
-7.0
Selected states§§
States with very good to excellent reporting (n = 27)
Alaska
94
12.5
102
13.9
1.4
11.2
51
6.8
51
7.0
0.2
2.9
Connecticut
855
24.5
955
27.7
3.2***
13.1***
264
7.2
273
7.7
0.5
6.9
District of Columbia
209
30.0
244
34.7
4.7
15.7
66
9.3
58
8.4
-0.9
-9.7
Georgia
918
8.8
1,014
9.7
0.9***
10.2***
536
5.1
568
5.4
0.3
5.9
Hawaii
77
5.2
53
3.4
-1.8
-34.6
55
3.6
40
2.5
-1.1
-30.6
Illinois
1,947
15.3
2,202
17.2
1.9***
12.4***
479
3.7
623
4.8
1.1***
29.7***
Iowa
183
6.2
206
6.9
0.7
11.3
92
3.1
104
3.4
0.3
9.7
Maine
301
25.2
360
29.9
4.7***
18.7***
154
12.5
100
7.6
-4.9***
-39.2***
Maryland
1,821
29.7
1,985
32.2
2.5***
8.4***
812
13.1
711
11.5
-1.6***
-12.2***
Massachusetts
1,990
29.7
1,913
28.2
-1.5
-5.1
351
4.9
321
4.6
-0.3
-6.1
Nevada
408
13.3
412
13.3
0.0
0.0
275
8.9
276
8.7
-0.2
-2.2
New Hampshire
437
35.8
424
34.0
-1.8
-5.0
89
6.5
62
4.8
-1.7
-26.2
New Mexico
349
17.5
332
16.7
-0.8
-4.6
186
9.2
171
8.5
-0.7
-7.6
New York
3,009
15.1
3,224
16.1
1.0***
6.6***
1,100
5.4
1,044
5.1
-0.3
-5.6
North Carolina
1,506
15.4
1,953
19.8
4.4***
28.6***
695
6.9
659
6.5
-0.4
-5.8
Ohio
3,613
32.9
4,293
39.2
6.3***
19.1***
867
7.7
947
8.4
0.7
9.1
Oklahoma
444
11.6
388
10.2
-1.4
-12.1
322
8.4
251
6.7
-1.7***
-20.2***
Oregon
312
7.6
344
8.1
0.5
6.6
165
3.9
154
3.5
-0.4
-10.3
Rhode Island
279
26.7
277
26.9
0.2
0.7
114
10.5
99
8.8
-1.7
-16.2
South Carolina
628
13.1
749
15.5
2.4***
18.3***
381
7.8
345
7.1
-0.7
-9.0
Tennessee
1,186
18.1
1,269
19.3
1.2
6.6
739
11.1
644
9.6
-1.5***
-13.5***
Utah
466
16.4
456
15.5
-0.9
-5.5
349
12.5
315
10.8
-1.7
-13.6
Vermont
101
18.4
114
20.0
1.6
8.7
35
5.9
40
6.3
0.4
6.8
Virginia
1,130
13.5
1,241
14.8
1.3***
9.6***
400
4.7
404
4.7
0.0
0.0
Washington
709
9.4
742
9.6
0.2
2.1
388
5.0
343
4.3
-0.7***
-14.0***
West Virginia
733
43.4
833
49.6
6.2***
14.3***
340
19.7
304
17.2
-2.5
-12.7
Wisconsin
866
15.8
926
16.9
1.1
7.0
382
6.7
362
6.4
-0.3
-4.5
States with good reporting (n = 8)
Arizona
769
11.4
928
13.5
2.1***
18.4***
380
5.6
414
5.9
0.3
5.4
California
2,012
4.9
2,199
5.3
0.4***
8.2***
1,172
2.8
1,169
2.8
0.0
0.0
Colorado
536
9.5
578
10.0
0.5
5.3
258
4.5
300
5.1
0.6
13.3
Kentucky
989
23.6
1,160
27.9
4.3***
18.2***
429
10.0
433
10.2
0.2
2.0
Michigan
1,762
18.5
2,033
21.2
2.7***
14.6***
678
7.0
633
6.5
-0.5
-7.1
Minnesota
396
7.4
422
7.8
0.4
5.4
195
3.6
195
3.6
0.0
0.0
Missouri
914
15.9
952
16.5
0.6
3.8
268
4.5
253
4.1
-0.4
-8.9
Texas 1,375 4.9 1,458 5.1 0.2 4.1 617 2.2 646 2.3 0.1 4.5

Source: National Vital Statistics System, Mortality file.

* Deaths are classified using the International Classification of Diseases, Tenth Revision (ICD–10). Drug overdose deaths are identified using underlying cause-of-death codes X40–X44, X60–X64, X85, and Y10–Y14. Rates are age-adjusted using the direct method and the 2000 U.S. standard population, except for age-specific crude rates. All rates are per 100,000 population.

Drug overdose deaths, as defined, that have opium (T40.0), heroin (T40.1), natural and semisynthetic opioids (T40.2), methadone (T40.3), synthetic opioids other than methadone (T40.4), or other and unspecified narcotics (T40.6) as a contributing cause.

§ Drug overdose deaths, as defined, that have natural and semisynthetic opioids (T40.2) or methadone (T40.3) as a contributing cause.

Categories of deaths are not exclusive because deaths might involve more than one drug. Summing of categories will result in more than the total number of deaths in a year.

** Data for Hispanic origin should be interpreted with caution; studies comparing Hispanic origin on death certificates and on census surveys have shown inconsistent reporting on Hispanic ethnicity. Potential race misclassification might lead to underestimates for certain categories, primarily American Indian/Alaska Native non-Hispanic and Asian/Pacific Islander non-Hispanic decedents. https://www.cdc.gov/nchs/data/series/sr_02/sr02_172.pdf.

†† By 2013 urbanization classification (https://www.cdc.gov/nchs/data_access/urban_rural.htm).

§§ Analyses were limited to states meeting the following criteria. For states with very good to excellent reporting, ≥90% of drug overdose deaths mention at least one specific drug in 2016, with the change in drug overdose deaths mentioning at least one specific drug differing by <10 percentage points from 2016 to 2017. States with good reporting had 80% to <90% of drug overdose deaths mention at least one specific drug in 2016, with the change in the percentage of drug overdose deaths mentioning at least one specific drug differing by <10 percentage points from 2016 to 2017. States included also were required to have stable rate estimates, based on ≥20 deaths, in at least two drug categories (i.e., opioids, prescription opioids, synthetic opioids other than methadone, and heroin).

¶¶ Absolute rate change is the difference between 2016 and 2017 rates. Percent change is the absolute rate change divided by the 2016 rate, multiplied by 100. Nonoverlapping confidence intervals based on the gamma method were used if the number of deaths was <100 in 2016 or 2017, and z-tests were used if the number of deaths was ≥100 in both 2016 and 2017.

*** Statistically significant (P-value <0.05).